CRISPR Screen Reveals How Ovarian Cancer Cells Resist Niraparib
A genome-wide CRISPR screen identifies UGCG-driven sphingolipid metabolism and protective autophagy as drivers of Niraparib resistance in ovarian cancer.
A genome-wide CRISPR screen identifies UGCG-driven sphingolipid metabolism and protective autophagy as drivers of Niraparib resistance in ovarian cancer.
A new human cell model shows that astrocytes lacking the prion protein display increased reactivity markers and mitochondrial abnormalities, yet ...
A preclinical study reports that formononetin from Jianpi Tongluo Formula suppresses colorectal cancer progression by inhibiting M2 tumor-associated macrophage polarization ...
A new review in Medical Oncology examines how organoid and assembloid technologies could overcome the limits of conventional models in ...
A new review maps which engineered organoid platforms can turn gut microbiota-cancer associations into causal evidence, and where the current ...
A new review argues that organoids, 3D-bioprinted tissues and organ-on-a-chip systems are replacing traditional cell and animal models in radiation ...
In a laboratory in Chengdu, China, tiny three-dimensional structures have begun to bloom from pieces of human vaginal wall tissue, ...
Preclinical experiments found that tetrandrine promoted ferroptosis in NSCLC models, enhanced CD8⁺ T-cell effector responses and improved anti-PD-1 tumor suppression ...
A two-stage culture system expanded mouse hepatocytes and produced organoids with partial recovery of hepatic metabolism, zonation-related responses and urea ...
Hundreds of patient-derived cancer models expanded dependency mapping and revealed vulnerabilities linked to mutations, cellular states and treatment history, while ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine